Related Experiment Videos
Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase
Prem L Sharma1, Viktoria Nurpeisov, Brenda Hernandez-Santiago
1Department of Pediatrics, Laboratory of Biochemical Pharmacology, Emory University School of Medicine, Atlanta, Georgia, USA.
Current Topics in Medicinal Chemistry
|May 12, 2004
Summary
New nucleoside reverse transcriptase inhibitors (NRTIs) are crucial for HIV-1 treatment, but their long-term use causes toxicity and resistance. Understanding NRTI resistance pathways is key for developing safer, more effective HIV therapies.
Area of Science:
- Virology
- Infectious Diseases
- Pharmacology
Background:
- Human immunodeficiency virus type 1 (HIV-1) drug development focuses on inhibiting wild type and resistant strains.
- Combination therapy with nucleoside reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), and protease inhibitors (PI) is standard for HIV/AIDS.
- NRTIs, while less potent than NNRTIs or PIs, are essential in highly active antiretroviral therapy (HAART) due to their role in enhancing regimen potency and daily dosing.
Purpose of the Study:
- To address the need for novel compounds that inhibit both wild-type and resistant HIV-1 strains.
- To highlight the ongoing importance of NRTIs in HAART regimens.
- To investigate the mechanisms of NRTI-associated toxicity and resistance.
Main Methods:
- Review of clinical trial data on NRTI efficacy and adverse events.
- Analysis of the molecular mechanisms underlying NRTI toxicity, including lactic acidaemia, hepatic steatosis, and peripheral neuropathy.
- Examination of resistance pathways, focusing on the role of pyrophosphorolysis in NRTI discrimination and excision.
Main Results:
- Prolonged NRTI use is associated with class-related toxicities like lactic acidaemia and hepatic steatosis, linked to mitochondrial damage.
- Development of resistance-conferring mutations limits the long-term effectiveness of current NRTIs.
- The efficiency of pyrophosphorolysis is a critical factor determining the emergence of specific NRTI resistance pathways.
Conclusions:
- NRTIs remain indispensable components of HAART, despite their limitations.
- Understanding NRTI resistance mechanisms, particularly pyrophosphorolysis, is vital for designing next-generation antiretrovirals.
- Further research into novel NRTIs with improved safety and resistance profiles is necessary for effective long-term HIV disease management.